275 related articles for article (PubMed ID: 26179325)
21. Pathological review of cardiac amyloidosis using autopsy cases in a single Japanese institution.
Tateishi Y; Yamada Y; Katsuki M; Nagata T; Yamamoto H; Kohashi K; Koga Y; Hashisako M; Kiyozawa D; Mori T; Kuboyama Y; Kakinokizono A; Miyazaki Y; Yamaguchi A; Tsutsui H; Ninomiya T; Naiki H; Oda Y
Pathol Res Pract; 2021 Nov; 227():153635. PubMed ID: 34653913
[TBL] [Abstract][Full Text] [Related]
22. Amyloidosis causing a progressive myopathy.
Nadkarni N; Freimer M; Mendell JR
Muscle Nerve; 1995 Sep; 18(9):1016-8. PubMed ID: 7643863
[TBL] [Abstract][Full Text] [Related]
23. [Amyloidoma Adjacent to the Thoracic Vertebral Body Developed into Systemic Amyloid Light-chain amyloidosis].
Tanaka K; Goto H; Ikeda S; Masumoto N; Watanabe K; Tsubakihara M
Kyobu Geka; 2017 Aug; 70(9):755-757. PubMed ID: 28790241
[TBL] [Abstract][Full Text] [Related]
24. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
[TBL] [Abstract][Full Text] [Related]
25. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
Westermark GT; Westermark P
FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
[TBL] [Abstract][Full Text] [Related]
26. Sudden death possibly related to lenalidomide given for cardiac and muscle AL amyloidosis secondary to light chain deposition disease.
Finsterer J; Höftberger R; Stöllberger C; Wöhrer A; Regele H
J Oncol Pharm Pract; 2013 Jun; 19(2):170-4. PubMed ID: 22504167
[TBL] [Abstract][Full Text] [Related]
27. Neuromuscular amyloidosis: Unmasking the master of disguise.
Pinto MV; Dyck PJB; Liewluck T
Muscle Nerve; 2021 Jul; 64(1):23-36. PubMed ID: 33458861
[TBL] [Abstract][Full Text] [Related]
28. Case report: Rapid development of amyloid A amyloidosis in temporal arteritis with
Yoshida S; Matsumoto H; Temmoku J; Shakespear N; Kiko Y; Kikuchi K; Sumichika Y; Saito K; Fujita Y; Matsuoka N; Asano T; Sato S; Suzuki E; Watanabe H; Ohira H; Migita K
Front Immunol; 2023; 14():1144397. PubMed ID: 37026007
[TBL] [Abstract][Full Text] [Related]
29. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
Yamada Y; Ueno T; Irifuku T; Nakashima A; Doi S; Ichinohe T; Masaki T
Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
[TBL] [Abstract][Full Text] [Related]
30. Fatal gastrointestinal hemorrhage in a paraplegic man with undiagnosed AA (secondary) amyloidosis.
Baird-Howell MA; Wurzel J
Amyloid; 2011 Dec; 18(4):245-8. PubMed ID: 22014073
[TBL] [Abstract][Full Text] [Related]
31. Interstitial amyloidosis in sporadic inclusion body myositis.
Alamr M; Milone M; Naddaf E; Ytterberg SR; Steel SJ; Jones LK; Liewluck T
Muscle Nerve; 2021 Nov; 64(5):590-594. PubMed ID: 34196979
[TBL] [Abstract][Full Text] [Related]
32. AA amyloidosis complicating the hereditary periodic fever syndromes.
Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
[TBL] [Abstract][Full Text] [Related]
33. Histological evaluation of the distribution of systemic AA-amyloidosis in nine domestic shorthair cats.
Moccia V; Vogt AC; Ricagno S; Callegari C; Vogel M; Zini E; Ferro S
PLoS One; 2023; 18(11):e0293892. PubMed ID: 37917747
[TBL] [Abstract][Full Text] [Related]
34. AA-type amyloidosis associated with non-Hodgkin's lymphoma: a case report.
Zhu LC; Sidhu GS; Yee HT; Cassai ND; Goldfarb DS; Wieczorek RL
Hum Pathol; 2004 Aug; 35(8):1041-4. PubMed ID: 15297973
[TBL] [Abstract][Full Text] [Related]
35. Systemic AA amyloidosis.
Pinney JH; Lachmann HJ
Subcell Biochem; 2012; 65():541-64. PubMed ID: 23225016
[TBL] [Abstract][Full Text] [Related]
36. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
37. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
Carr AS; Pelayo-Negro AL; Jaunmuktane Z; Scalco RS; Hutt D; Evans MR; Heally E; Brandner S; Holton J; Blake J; Whelan CJ; Wechalekar AD; Gillmore JD; Hawkins PN; Reilly MM
Neuromuscul Disord; 2015 Jun; 25(6):511-5. PubMed ID: 25819286
[TBL] [Abstract][Full Text] [Related]
38. Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.
Westermark GT; Fändrich M; Lundmark K; Westermark P
Cold Spring Harb Perspect Med; 2018 Jan; 8(1):. PubMed ID: 28108533
[TBL] [Abstract][Full Text] [Related]
39. [Case of amyloidosis with amyloid deposition detected only in skeletal muscles].
Ohtsuka Y; Yasui N; Sekiguchi K; Kowa H; Nishino I; Kanda F; Toda T
Rinsho Shinkeigaku; 2012; 52(10):739-43. PubMed ID: 23064623
[TBL] [Abstract][Full Text] [Related]
40. [Pseudo-hypertrophic pelvi-crural amyloid myopathy in lambda light-chain myeloma. Clinical, morphological and immunocytochemical study].
Pellissier JF; Aquilina C; Murisasco A; Toga M
Rev Neurol (Paris); 1987; 143(2):128-36. PubMed ID: 3110902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
